Retatrutide.

Triple GLP-1/GIP/glucagon agonist, still under active clinical investigation.

Per cartridge €340.00

Adding to your bag reserves your order and takes payment now. Your practitioner reviews it against your questionnaire and bloodwork immediately after (usually same day) before anything ships. Declined orders are refunded in full. Exact dosing instructions are set individually as part of your reviewed protocol, not published here.

About Retatrutide.

Triple GLP-1/GIP/glucagon agonist, still under active clinical investigation. Research and practitioner-review use only. This page is descriptive, not a self-administration guide. Your specific protocol, dosing and cycle length are set individually once your questionnaire and bloodwork have been reviewed.

NameRetatrutide

FormCartridge · subcutaneous, via reusable pen

Identity & purityHPLC + MS · > 98%

EndotoxinsLAL assay, batch-tested

Cold chainValidated 2–8 °C, monitored end-to-end

Review basisSigna practitioner review: see Our practitioners

Within Weight Management.

All Weight Management peptides →

Your bag

0 items

Loading…